Genentech Invests $750M in Oregon | Portland News

Genentech is pouring $750 million into a new manufacturing hub in Hillsboro, Oregon, to build cutting-edge drug delivery systems like pre-filled syringes and auto-injectors—critical for getting life-saving treatments to patients faster. This major expansion builds on their existing campus, which opened in 2006 and has become a cornerstone of U.S. manufacturing. The project will create 450 new jobs—250 in advanced manufacturing and 200 in construction—fueling local economic growth. Governor Tina Kotek applauds the move as a win for Oregon’s bioscience sector, boosting innovation and job quality across communities. Completion is targeted for 2031, signaling Genentech’s long-term commitment to U.S. manufacturing roots right here in Oregon. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/686f80ef671fc12a